Biological and Clinical Database for Pancreatic Adenocarcinoma (BACAP)
Sponsor: University Hospital, Toulouse
Listed as NCT02818829, this observational or N/A phase trial focuses on Pancreatic Adenocarcinoma and remains ongoing. Sponsored by University Hospital, Toulouse, it has been updated 17 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
17 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Apr 2025 — Sep 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Recruiting
Status: Unknown → Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
▶ Show 12 earlier versions
-
Sep 2022 — Jul 2024 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
-
Aug 2019 — Aug 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jul 2018 — Aug 2019 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Toulouse
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bordeaux, France , Clichy, France , Lille, France , Lyon, France , Marseille, France , Montpellier, France , Nice, France , Paris, France , Pau, France , Toulouse, France and 1 more location